INTRODUCTION
Adenosine is one of the key modulators of the human body and acts through four different receptor subtypes: the A 1 , A 2A , A 2B , and A 3 receptors, respectively (A1AR, A2AAR, A2BAR, and A3AR). The A3AR was identified in the late 1990´s, and, so far, there is little data available describing its distribution and density in vivo. The most suitable technique to collect these lacking data in the living *Address correspondence to this author at the Department of Nuclear Medicine, AKH Wien, Waehringer Guertel 18-20, A-1090 Vienna, Austria; Tel: +43 1 40400 1557; Fax: +43 1 40400 1559; E-mail: markus.mitterhauser@meduniwien.ac.at organism would be PET (positron emission tomography). As a premise for molecular PET imaging with high quality, there is need for suitable radioligands displaying high affinity, high selectivity and low unspecific binding. Also, the absence of interfering radioactive metabolites in the target tissue is of importance. Beside these prerequisites, the most important premise for a successful PET-tracer is its widespread availability and reliable preparation. Additionally, to keep radiation burden for the operators as low as possible, a fully automated preparation would be beneficial.
Recently, we introduced [ 18 F]FE@SUPPY (5-(2-[
18 F]fluoroethyl) 2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate) as the first PET-tracer for the A3AR [1, 2] . The radiosynthesis was performed in a simple one-pot one-step reaction with good and reliable radiolabeling yields and good specific radioactivities. [ 18 F]FE@SUPPY was selected due to its favorable binding characteristics for the A3AR out of the well characterized chemical family of 3,5-diacyl-2,4-dialkylpyridines -with all derivatives showing considerable affinity for the adenosine receptor system [3] . Regarding the metabolic profile -these diacylderivatives all carry two ester moieties within one molecule, one carboxylic and one thiocarboxylic -enzymes derived from the family of carboxylesterases would be expected to significantly contribute to cleavage and degradation [4, 5] . To the best of our knowledge, there is no conclusive data regarding differences in stability of carboxylic and thiocarboxylic esters within one molecule. In a comparative study, Azema et al. [6] 
MATERIALS AND METHODS

General
Mass spectra were obtained on a Shimadzu QP 1000 instrument (EI, 70 eV; Shimadzu, Kyoto, Japan). IR spectra were recorded on a Perkin-Elmer FTIR spectrum 1000 spectrometer (Perkin Elmer, Watford, UK). Elemental analyses were performed at the Microanalytical Laboratory at the University of Vienna, Austria (http://www.univie.ac.at/Mikrolabor/ind_eng.htm).
1 H-and 13 C-NMR spectra were recorded on a Bruker Avance DPX-200 spectrometer at 27°C (200.13 MHz for 1 H, 50.32 MHz for 13 C; Bruker AXS GmbH, Karlsruhe, Germany). High resolution mass spectroscopy was performed on a Finnigan MAT 8230 (EI; 70eV; Thermo Finnigan Waltham, MA, USA). Radioanalytical thin-layer chromatography (radio-TLC) was performed using silicagel 60F 254 plates from Merck (Darmstadt, Germany). Analysis of radio-TLC plates and autoradiography were performed using a Canberra-Packard Instant Imager (Perkin Elmer, Watford, UK). Analytical highperformance liquid chromatography (HPLC) was performed using a Merck-Hitachi LaChrom system with a NaIradiodetector from Berthold Technologies (Bad Wildbach, Germany). The semi-preparative HPLC system (as part of the GE TRACERlab Fx FN synthesizer) consisted of a Sykam S1021 pump (Sykam GmbH, Eresing, Germany) and a UV detector (254 nm) and a radioactivity detector in series. This precursor was prepared as described previously [1, 2, 7] . Briefly, OH@SUPPY, prepared according to [8] was reacted with toluene-4-sulfonyl chloride in THF and purified by recrystallization. A solution of toluene-4-sulfonyl chloride (1.64g, 8.59mmol) in THF (15mL) was added to OH@SUPPY:2 [8] (1.69g, 4.36mmol) and triethylamine (1.18g, 1.6ml, 11.67mmol) in THF (40mL) at 0°C. Then the reaction mixture was refluxed and the solvent was evaporated in vacuo. The residue was purified via column chromatography. The reference compound was obtained according to [1, 2, 7] . Briefly, OH@SUPPY [8] was treated with diethylaminosulfur trifluoride (DAST) at -78°C. Purification was performed using column chromatography. dichloromethane at -78°C. After hydrolysis, purification was performed using column chromatography.
5-Ethyl
Automated Radiosynthesis -[ 18 F]FE@SUPPY and [ 18 F]FE@SUPPY:2
The automated preparation of both fluorinated FE@SUPPY analogs was preformed on a GE TRACERlab Fx FN synthesizer. A comprehensive overview of all components of the system is given in Fig. (2) . The following preparation steps were performed prior to synthesis start: a C18plus SPE cartridge (360mg, SepPak ® Waters) and a PS-HCO3 SPE cartridge (45mg, Macherey-Nagel) were placed on their designated spots and connected to the corresponding tubing. The vials were filled with the following solutions: vial 1 -Kryptofix K2. 18 F reaction in a GE Gen2-silver target filled with 2.4mL [
18 O]water (>98%) and delivered to a 5mL vvial. This vial was placed on the designated spot of the synthesizer (left hand side, see Fig. 2 ) and connected. Then, vacuum was applied and [
18 F]fluoride was sucked over the anion exchange cartridge on-line (via V10 and V11) and separated from excess water. [ 18 F]fluoride was eluted with a solution containing Kryptofix 2.2.2. and potassium carbonate in acetonitrile/water into the reactor (V1, V10, V11, V13). The resulting solution was heated for 2 minutes at 60°C and acetonitrile was added (V2). Heating was continued for another 3min at 60°C and then for 5min at 120°C in a stream of helium (V20) while adding the final portion of acetonitrile (V3) to complete azeotropic drying. The dried [
18 F]fluorideaminopolyether complex was cooled to 65°C, precursor was added (V4) and the mixture was heated to 75°C for 18min. After cooling to 35°C, the crude reaction mixture was quenched with water (V5) and transferred (V14) to the injec- tor of the semi-preparative reversed-phase HPLC system (column: Merck Chromolith ® SemiPrep RP-18e, 100x10mm, mobile phase: acetonitrile/water/acetic acid (60/38.8/1.2 v/v/v; 2.5 g/L ammonium acetate; pH 3.2); flow: 10 mL/min). Triggered by the fluid detector, the injector automatically changed from the "load" to the "inject" position and the chromatographic plotting started. Using the presettings from our evaluation runs, the desired peak was cut automatically and collected in the round bottom flask (V18). The diluted solution was transferred over a C18plus SepPak ® in a stream of helium (V17, V21). After washing with water (V9), the purified product was eluted with ethanol (V8) directly into a sterile vial within a laminar air-flow hot-cell (V15) and on-line sterile filtered (0.22 m). The product was diluted and formulated using physiological saline (V7).
Biodistribution Experiments
The experiments were approved by the Austrian law on animal experiments and the procedure followed the protocol established in various previous studies of our group. Male Sprague-Dawley rats/Him:OFA (n=20, 271-346 g) were injected with 2.17-7.52 MBq (180-225 L) through a tail vein. Subsequently, individuals were sacrificed by exsanguination from the abdominal aorta in ether anaesthesia after 5, 15, 30, 60 and 120 minutes (n=4 each). Organs were removed, dry weighed and counted. Results are expressed as percent injected dose per gram tissue (% I.D./g).
Lipophilicity
The lipophilicity of the title compounds was determined using an HPLC assay based on Donovan and Pescatore [9] . Briefly, a short octadecyl-poly(vinyl alcohol) HPLC column (Supelco ODP-50; 4.6 x 20mm) was eluted with a flow rate of 2mL/min. A linear gradient from 10 to 100% methanol (organic phase) within 7 min was applied and buffers for pH 2, 7.4 and 10 (aqueous phase) were prepared; UV-detection was done at 270 nm. Toluene and triphenylene (dissolved in methanol) were used as internal standards and the injection volume was 20 L. Between consecutive HPLC runs, 5min for re-equilibration of the HPLC column were allowed. The HPLC logP of a compound was then determined using the following equation:
where logP tol and logP tri are the logP values for toluene and triphenylene, respectively, from the literature [10] and t R,tol and t R,tri are the retention times for toluene and triphenylene, respectively, determined in the HPLC run. t R,x is the retention time of the compound.
c logP-values were calculated based on the structural formulas of the compounds using the logP add-on within the ACD/chemsketch software (ACD labs; version 11.01; October 2007). The described automated preparation of both fluorinated FE@SUPPY analogs was set up using standard PET radiochemistry equipment. The whole preparation including radiosynthesis, purification, sterile filtration and formulation was completed within 70-80min. Semi-preparative HPLC revealed consistent retention patterns for [ 18 
RESULTS
Precursor Chemistry
Biodistribution Experiments
All values are shown in Table 1 . The organ with the lowest uptake was fat showing 0.05 ± 0.02% I.D./g after 5 minutes, followed by lung (0.07 ± 0.05% I.D./g), spleen (0.07 ± 0.03% I.D./g) and brain (0.07 ± 0.01% I.D./g, all values after 120 minutes). Organs with highest uptake were bowels with 1.45 ± 0.97% I.D./g after 15 minutes followed by the liver showing 1.08 ± 0.39% I.D/g after 5 minutes. Other organs with pronounced uptake were kidney and heart. Blood activity was 0.12-0.18% I.D./g throughout the whole experiment. Remaining activity in the carcass was 0.15-0.39% I.D./g.
Lipophilicity
We found retention times of 4. Table 2 . All HPLC-experiments were repeated at least 4-times; given values are arithmetic means.
DISCUSSION
General
Collectively, adenosine receptors are widespread on virtually every organ and tissue and represent promising drug targets for pharmacological intervention in many pathophysiological conditions such as asthma, neurodegenerative disorders, chronic inflammatory diseases, and cancer. The A3AR is the most recently identified adenosine receptor and its involvement in tumors has recently been shown: the A3ARs are highly expressed on the cell surface of tumor cells [11] [12] [13] [14] [15] [16] and in human enteric neurons [17] but not in the majority of normal tissues [15] . In a very comprehensive study, A3AR mRNA expression in various tumor tissues was tested using reverse transcription-PCR analysis and A3AR protein expression was studied in fresh tumors and was correlated with that of the adjacent normal tissue. The authors conclude that primary and metastatic tumor tissues highly express A3AR indicating that high receptor expression is a characteristic of solid tumors. These findings suggest the A3AR as a potential target for tumor growth intervention or imaging [18] . The A3ARs are also known to be involved in many other diseases, such as cardiac [19] and cerebral ischemia [20] , glaucoma [21] , stroke [22] and epilepsy [23] .
Li et al. [3] published a series of chemical structures, with most of them displaying reasonable affinities for the A3AR. Amongst all the investigated structures, FE@SUPPY (Fig. 1) was the most affine compound for the A3AR (K i 4.22 nM) and thus was selected and developed as [
18 F]FE@SUPPY, the first PET-tracer [1, 2] . Hence, having developed a series of fluoroethyl-esters over the last five years [24] [25] [26] [27] [28] [29] , it was obvious for us to develop [ 18 F]FE@SUPPY:2. 
Precursor and Reference Standard
Organic chemistry of precursor and reference molecules were accomplished in straightforward procedures. Preparations and purifications were performed with good yields; unexpectedly the tosylation reactions for both precursors were time-consuming. 18 F]fluoride, corrected for decay). Nucleophilic substitution of the tosyl-leaving group on a thiocarboxylic ester moiety therefore seems to be slower than on a carboxylic ester. Interestingly, the found specific radioactivities were dramatically higher for [ 18 F]FE@SUPPY:2.
Biodistribution Experiments
As presented in Table 1 , organs displaying highest uptake were the bowels, followed by liver. Initially, uptake in the kidneys was high, too, yet decreasing significantly after 15 minutes. Since our group has demonstrated recently that [
18 F]fluoroethyl esters are primarily metabolized by carboxylic esterases, high kidney uptake could be explained by the renal excretion route of the major expected metabolite, [ 18 F]fluoroethanol [30, 31] . High liver uptake could be explained by metabolism taking place in the cytochrome P-450-rich hepatosomes. explanation for this phenomenon.
Lipophilicity
As a prerequisite for its successful application as a radiopharmaceutical, a molecule has to exhibit several properties: it should be widely available, it should accumulate in the target tissue in stable condition and within a reasonable time flow and it should bind to the desired structures (receptor sites, enzymes, transporters, proteins…) with high affinity, selectivity and specificity. Since logP is known to influence many of these pharmacokinetic and pharmacodynamic parameters, especially unspecific binding of radiopharmaceuticals and blood brain barrier permeability [32] , we tried to pay specific deference to this measure although we are well aware of the fact, that logP is of limited value as a predictor for lipophilicity. Nevertheless, it is the most commonly used and prominent measure.
LogP (or more precisely OW logP where OW stands for octanol/water) is defined as the decadal logarithm of the partition coefficient between equal volumes of 1-octanol and water. Normally, an aliquot of the solid compound is dissolved directly in a mixture of 1-octanol and water, the phases are separated and then the content is determined using e.g. chromatographic or spectroscopic methods. But in the case of radiopharmaceutical preparations, on the one hand, one has the advantage of using the radioactivity for very accurate measurement of the product concentration but, on the other hand, one rarely has access to solid compounds. Furthermore, the final preparation is always contaminated by small amounts of other radioactive species (e.g. by-products, educts…). Even these small amounts (1-3%) would significantly bias the outcome of the measurement of the OW logP: if, for instance, the final product solution of a typical lipophilic compound displayed a radiochemical purity of 99% and the remaining 1% could be attributed to a contamination with hydrophilic [
18 F]fluoride, the partition coefficient would never be higher than 99 to 1 and therefore the OW logP measurement would always give a result lower than 2! Thus, optimized methods have been proposed to overcome this problem [33] . In our mind, the most elegant solution to get an accurate and simple measure of the lipophilicity is using the HPLC logP instead of OW logP. Since contaminations are separated within the HPLC run they do not interfere with the retention of the main compound. Additionally, the used HPLC method is very simple and inexpensive, it may be used both with radioactive and non-radioactive compounds and the pH of the aqueous phase may be adjusted easily to whatever value is desired.
As shown in Table 2 
